Contact Us | Legal

Investor Relations

The investor pages that follow are your resource for financial information about Progenics Pharmaceuticals, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Recent Releases

Jun 11, 2013
Salix and Progenics Announce FDA Advisory Committee to Review Relistor sNDA for Opioid-Induced Constipation in Patients with Chronic Pain

Jun 10, 2013
Progenics Pharmaceuticals Presents PSMA-Related Data at SNMMI 2013

Jun 1, 2013
Progenics Pharmaceuticals' Data From a Phase 1 Study of PSMA ADC Presented at ASCO 2013

more »

Events

Jun 5, 2013
Jefferies Global Healthcare Conference

Jun 1, 2013
ASCO 2013

more »